SMAD7 and metabolic syndrome: Interestingly, we observed that Smad7, which inhibits muscle atrophy by attenuating MYOST signaling, was significantly upregulated in soleus muscle from control and MetS rats treated with R+Q as compared to their respective group without treatment.